SCHEMBL3069897

SCHEMBL3069897

OCc1c#cccc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3681698 0.75
SCHEMBL10072430 0.75
SCHEMBL21168527 0.72 POLB (0.34)
SCHEMBL3916924 0.70
SCHEMBL15280177 0.70
SCHEMBL10463113 0.67 TSHR (0.36)
SCHEMBL41215 0.67
SCHEMBL21300040 0.66 CA1 (0.34)
SCHEMBL16215706 0.66
SCHEMBL17613121 0.66 MAOA (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115068425-A Method for producing phenylephrine resinate particles, phenylephrine resinate particles and use thereof in medicaments 强生消费者公司 2022-09-20 CN disclosed
US-20210330614-A1 PROCESS FOR MANUFACTURING PHENYLEPHRINE RESINATE PARTICLES; PHENYLEPHRINE RESINATE PARTICLES; AND USE OF PHENYLEPHRINE RESINATE PARTICLES IN PHARMACEUTICAL FORMULATIONS JOHNSON & JOHNSON CONSUMER INC. 2021-10-28 US disclosed
US-20210322558-A1 PHENYLEPHRINE RESINATE PARTICLES AND USE THEREOF IN PHARMACEUTICAL FORMULATIONS JOHNSON & JOHNSON CONSUMER INC. 2021-10-21 US disclosed
EP-2968223-B1 PHENYLEPHRINE RESINATE PARTICLES JOHNSON & JOHNSON CONSUMER INC (US) 2020-10-28 EP disclosed
EP-2968224-B1 PHENYLEPHRINE RESINATE PARTICLES AND USE THEREOF IN PHARMACEUTICAL FORMULATIONS JOHNSON & JOHNSON CONSUMER INC (US) 2020-10-28 EP disclosed
US-9833510-B2 Modified release solid or semi-solid dosage forms JOHNSON & JOHNSON CONSUMER INC. (US) 2017-12-05 US disclosed
EP-3229787-A1 PROCESS FOR MANUFACTURING PHENYLEPHRINE RESINATE PARTICLES; PHENYLEPHRINE RESINATE PARTICLES; AND USE OF PHENYLEPHRINE RESINATE PARTICLES IN PHARMACEUTICAL FORMULATIONS Johnson & Johnson Consumer Inc. (US) 2017-10-18 EP disclosed
EP-2968188-B1 COATED PHENYLEPHRINE PARTICLES AND USE THEREOF IN PHARMACEUTICAL FORMULATIONS JOHNSON & JOHNSON CONSUMER INC (US) 2017-04-19 EP disclosed
EP-2180886-B1 MODIFIED RELEASE SOLID OR SEMI-SOLID DOSAGE FORMS JOHNSON & JOHNSON CONSUMER INC (US) 2016-09-21 EP disclosed
WO-2016094751-A1 PROCESS FOR MANUFACTURING PHENYLEPHRINE RESINATE PARTICLES; PHENYLEPHRINE RESINATE PARTICLES; AND USE OF PHENYLEPHRINE RESINATE PARTICLES IN PHARMACEUTICAL FORMULATIONS JOHNSON & JOHNSON CONSUMER INC. (US) 2016-06-16 WO disclosed
US-20100266699-A1 Pharmaceutical Suspensions and Related Methods JOHNSON & JOHNSON CONSUMER INC. 2010-10-21 US disclosed
EP-2180886-A2 MODIFIED RELEASE SOLID OR SEMI-SOLID DOSAGE FORMS McNeil-PPC, Inc. (US) 2010-05-05 EP disclosed
EP-2091515-A2 MODIFIED RELEASE ANALGESIC SUSPENSIONS McNeil-PPC, Inc. (US) 2009-08-26 EP disclosed
EP-2046291-A1 PHARMACEUTICAL SUSPENSIONS COMPRISING PHENYLEPHRINE AND METHOD OF PREPARATION Mcneil-PPC, Inc (US) 2009-04-15 EP disclosed
WO-2008157103-A2 MODIFIED RELEASE SOLID OR SEMI-SOLID DOSAGE FORMS MCNEIL-PPC, INC. (US) 2008-12-24 WO disclosed
US-20080311201-A1 MODIFIED RELEASE SOLID OR SEMI-SOLID DOSAGE FORMS JOHNSON & JOHNSON CONSUMER INC. 2008-12-18 US disclosed
WO-2008064192-A2 MODIFIED RELEASE ANALGESIC SUSPENSIONS MCNEIL-PPC, INC. (US) 2008-05-29 WO disclosed
US-20080118571-A1 MODIFIED RELEASE ANALGESIC SUSPENSIONS JOHNSON & JOHNSON CONSUMER INC. 2008-05-22 US disclosed
WO-2008008944-A1 PHARMACEUTICAL SUSPENSIONS COMPRISING PHENYLEPHRINE AND METHOD OF PREPARATION MCNEIL-PPC, INC. (US) 2008-01-17 WO disclosed
US-20080014275-A1 PHARMACEUTICAL SUSPENSIONS AND RELATED METHODS JOHNSON & JOHNSON CONSUMER INC. 2008-01-17 US disclosed